Gain Therapeutics (GANX) Insider Trading & Ownership $1.88 +0.16 (+9.30%) (As of 08:00 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Gain Therapeutics (NASDAQ:GANX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.70%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$201,084.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$506.76 Get GANX Insider Trade Alerts Want to know when executives and insiders are buying or selling Gain Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GANX Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Gain Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/9/2024Gene MackCEOBuy14,400$1.01$14,544.00 8/9/2024Khalid IslamChairmanBuy50,000$1.00$50,000.00 7/1/2024Eric I RichmanDirectorBuy17,000$1.22$20,740.00 3/28/2024Jeffrey Scott RileyDirectorBuy30,000$3.86$115,800.00 12/21/2023Matthias AlderCEOSell206$2.46$506.76 (Data available from 1/1/2013 forward) GANX Insider Trading Activity - Frequently Asked Questions Who is on Gain Therapeutics's Insider Roster? The list of insiders at Gain Therapeutics includes Eric I Richman, Gene Mack, Jeffrey Scott Riley, Khalid Islam, and Matthias Alder. Learn more on insiders at GANX. What percentage of Gain Therapeutics stock is owned by insiders? 11.70% of Gain Therapeutics stock is owned by insiders. Learn more on GANX's insider holdings. Which Gain Therapeutics insiders have been buying company stock? The following insiders have purchased GANX shares in the last 24 months: Eric I Richman ($20,740.00), Gene Mack ($14,544.00), Jeffrey Scott Riley ($115,800.00), and Khalid Islam ($50,000.00). How much insider buying is happening at Gain Therapeutics? Insiders have purchased a total of 111,400 GANX shares in the last 24 months for a total of $201,084.00 bought. Which Gain Therapeutics insiders have been selling company stock? The following insider sold GANX shares in the last 24 months: Matthias Alder ($506.76). How much insider selling is happening at Gain Therapeutics? Insiders have sold a total of 206 Gain Therapeutics shares in the last 24 months for a total of $506.76 sold. Gain Therapeutics Key ExecutivesDr. Khalid Islam Ph.D. (Age 69)Founder & Chairman Compensation: $75kMr. Matthias Alder LIC. IUR. (Age 59)LL.M., President, CEO & Director Compensation: $593kMr. Gene Mack M.B.A.Chief Financial OfficerDr. Manolo Bellotto Ph.D. (Age 53)GM & Chief Strategy Officer Compensation: $251.99kDr. Joanne Taylor Ph.D.Senior Vice President of ResearchDr. Terenzio Ignoni Pharm.D.Senior Vice President of Technical OperationsDr. Jonas Hannestad M.D.Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies ADC Therapeutics Insider Selling Zura Bio Insider Selling Enanta Pharmaceuticals Insider Selling Neoleukin Therapeutics Insider Selling Caribou Biosciences Insider Selling 2seventy bio Insider Selling Nkarta Insider Selling Fulcrum Therapeutics Insider Selling Actuate Therapeutics Insider Selling LifeVantage Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:GANX) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gain Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gain Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GANX Stock Alerts